Skip to main content
Loading...
Menu social network
LinkedIn
Facebook
X
Youtube
Menu top
Assistance
User account menu
Log in
Main navigation
Home
Programme
Download the app
App
Download the app
App
Menu
Login
Close
Main navigation mobile
Home
Programme
Menu top
Assistance
Menu social network
LinkedIn
Facebook
X
Youtube
25 results
D3.274 - Feasibility of Digestive Enzyme Supplementation for Cow’s Milk Allergy in Exclusively Breastfed Infants
D3.271 - Development of a multiplex assay to assess the risk of IgE cross-reactivity to new protein sources
D3.275 - In silico based assessment of intrinsic protein features for ranking clinical relevance of plant-based food allergens
D3.277 - Tolerance to canned fish in patients allergic to β -parvalbumins
D3.278 - Tropomyosin-Driven Cross-Reactivity Between Shellfish and House Dust Mites: A Case Report
D3.279 - SWEET HONEY AND SOUR ALLERGIES: POLLEN-FOOD DEFENSIN CROSS-REACTIVITY - a case series
D3.281 - A Challenging Case of Paediatric Potato Allergy with Discordant Diagnostic Findings
D3.282 - A Case of Nonsteroidal Anti-Inflammatory Drug-Exacerbated Food Allergy
D3.280 - Severe Anaphylaxis Induced by Turkey Egg with Tolerance to Hen’s Egg and Poultry Meat: A First Report
D3.419 - Efficacy, safety, and remission outcomes of omalizumab in elderly patients with severe allergic asthma: a subgroup analysis by age of onset
D3.420 - Real-world epidemiologic characteristics of patients treated with dupilumab for type 2 inflammatory indications: a single-center retrospective cohort study
D3.422 - Dupilumab in children with multimorbid atopic phenotype: therapy efficacy, safety and biomarker changes
D3.424 - Retrospective Analysis of Self-Administration of Biologic Treatments for Severe Asthma and Chronic Urticaria
D3.426 - Predicting response to omalizumab in patients with chronic spontaneous urticaria: The first results of the global multicenter UCARE SCOPUS project
D3.427 - Challenging the paradigm: Use of omalizumab in refractory angioedema in a 2-year-old child
D3.428 - Substratification of Biologic Treatment Using Dupilumab in Eosinophilic COPD
D3.417 - Dupilumab in pediatric patients with severe atopic dermatitis
D3.485 - Prevalence of Ambrosia artemisiifolia in Italy: Bioinformatics and Botanical Aerobiology Analysis
D3.478 - Microsplenia: Spleen Size Reduction as a Comprehensive Biomarker for Immune-Related Diseases, Disease Monitoring, and Treatment Response
D3.479 - Association between Mitochondrial DNA Copy Number and Lung Function in Schoolchildren
Pagination
Current page
1
Page
2
Next page
Next
Last page
Last
Download the app
The congress at your fingertips
Available on
Download